APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Retinoids

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral Retinoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025195 pages

Choose your research edition.

Industry ResearchOral Retinoids Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Retinoids Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Oral Retinoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Retinoids Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Retinoids Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Oral Retinoids market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oral Retinoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Retinoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Retinoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral Retinoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Retinoids include Chongqing Huapont Pharmaceutical, Sichuan Med-Shine Pharmaceutical, Shandong Liangfu Pharmaceutical, Heilongjiang Fuhe Pharmaceutical, Harbin Dazhong Pharmaceutical, HEC Pharm, Zydus, Upsher-Smith and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Retinoids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Retinoids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Retinoids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Retinoids market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Retinoids Segment by Company

Chongqing Huapont Pharmaceutical

Sichuan Med-Shine Pharmaceutical

Shandong Liangfu Pharmaceutical

Heilongjiang Fuhe Pharmaceutical

Harbin Dazhong Pharmaceutical

HEC Pharm

Zydus

Upsher-Smith

Teva

Stiefel Laboratories

Sigmapharm Laboratories

Par Pharmaceutical

Mylan

Impax Laboratories

GlaxoSmithKline

Galderma Laboratories

Fuji Pharma

Dr. Reddy's Laboratories

Bausch Health

Barr Pharmaceuticals

Amneal Pharmaceuticals

Alembic

Actavis

Oral Retinoids Segment by Type

Alitretinoin

Acitretin

Bexarotene

Tretinoin

Isotretinoin

Oral Retinoids Segment by Application

Hospital and Clinic

Pharmacy

Other

Oral Retinoids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Retinoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Retinoids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Retinoids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Retinoids market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Retinoids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oral Retinoids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oral Retinoids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oral Retinoids Industry Trends Table 2. Oral Retinoids Industry Drivers Table 3. Oral Retinoids Industry Opportunities and Challenges Table 4. Oral Retinoids Industry Restraints Table 5. Global Oral Retinoids Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oral Retinoids Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oral Retinoids Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Oral Retinoids Sales Market Share by Manufacturers Table 9. Global Oral Retinoids Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Oral Retinoids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oral Retinoids Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oral Retinoids Manufacturers, Product Type & Application Table 13. Global Oral Retinoids Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Retinoids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Alitretinoin Table 17. Major Manufacturers of Acitretin Table 18. Major Manufacturers of Bexarotene Table 19. Major Manufacturers of Tretinoin Table 20. Major Manufacturers of Isotretinoin Table 21. Global Oral Retinoids Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Oral Retinoids Sales by Type (2021-2026) & (K Units) Table 23. Global Oral Retinoids Sales by Type (2027-2032) & (K Units) Table 24. Global Oral Retinoids Sales Market Share by Type (2021-2026) Table 25. Global Oral Retinoids Sales Market Share by Type (2027-2032) Table 26. Global Oral Retinoids Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Oral Retinoids Revenue by Type (2021-2026) & (K Units) Table 28. Global Oral Retinoids Revenue by Type (2027-2032) & (K Units) Table 29. Global Oral Retinoids Revenue Market Share by Type (2021-2026) Table 30. Global Oral Retinoids Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital and Clinic Table 32. Major Manufacturers of Pharmacy Table 33. Major Manufacturers of Other Table 34. Global Oral Retinoids Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Oral Retinoids Sales by Application (2021-2026) & (K Units) Table 36. Global Oral Retinoids Sales by Application (2027-2032) & (K Units) Table 37. Global Oral Retinoids Sales Market Share by Application (2021-2026) Table 38. Global Oral Retinoids Sales Market Share by Application (2027-2032) Table 39. Global Oral Retinoids Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Oral Retinoids Revenue by Application (2021-2026) & (K Units) Table 41. Global Oral Retinoids Revenue by Application (2027-2032) & (K Units) Table 42. Global Oral Retinoids Revenue Market Share by Application (2021-2026) Table 43. Global Oral Retinoids Revenue Market Share by Application (2027-2032) Table 44. Global Oral Retinoids Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Oral Retinoids Sales by Region (2021-2026) & (K Units) Table 46. Global Oral Retinoids Sales Market Share by Region (2021-2026) Table 47. Global Oral Retinoids Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Oral Retinoids Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Oral Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Oral Retinoids Sales by Country (2021-2026) & (K Units) Table 51. North America Oral Retinoids Sales by Country (2027-2032) & (K Units) Table 52. Europe Oral Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Oral Retinoids Sales by Country (2021-2026) & (K Units) Table 54. Europe Oral Retinoids Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Oral Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Oral Retinoids Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Oral Retinoids Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Oral Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Oral Retinoids Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Oral Retinoids Sales by Country (2027-2032) & (K Units) Table 61. Global Oral Retinoids Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Oral Retinoids Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Oral Retinoids Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Oral Retinoids Revenue Market Share by Region (2021-2026) Table 65. Global Oral Retinoids Revenue Market Share by Region (2027-2032) Table 66. Chongqing Huapont Pharmaceutical Company Information Table 67. Chongqing Huapont Pharmaceutical Business Overview Table 68. Chongqing Huapont Pharmaceutical Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Chongqing Huapont Pharmaceutical Oral Retinoids Product Portfolio Table 70. Chongqing Huapont Pharmaceutical Recent Development Table 71. Sichuan Med-Shine Pharmaceutical Company Information Table 72. Sichuan Med-Shine Pharmaceutical Business Overview Table 73. Sichuan Med-Shine Pharmaceutical Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sichuan Med-Shine Pharmaceutical Oral Retinoids Product Portfolio Table 75. Sichuan Med-Shine Pharmaceutical Recent Development Table 76. Shandong Liangfu Pharmaceutical Company Information Table 77. Shandong Liangfu Pharmaceutical Business Overview Table 78. Shandong Liangfu Pharmaceutical Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Shandong Liangfu Pharmaceutical Oral Retinoids Product Portfolio Table 80. Shandong Liangfu Pharmaceutical Recent Development Table 81. Heilongjiang Fuhe Pharmaceutical Company Information Table 82. Heilongjiang Fuhe Pharmaceutical Business Overview Table 83. Heilongjiang Fuhe Pharmaceutical Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Heilongjiang Fuhe Pharmaceutical Oral Retinoids Product Portfolio Table 85. Heilongjiang Fuhe Pharmaceutical Recent Development Table 86. Harbin Dazhong Pharmaceutical Company Information Table 87. Harbin Dazhong Pharmaceutical Business Overview Table 88. Harbin Dazhong Pharmaceutical Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Harbin Dazhong Pharmaceutical Oral Retinoids Product Portfolio Table 90. Harbin Dazhong Pharmaceutical Recent Development Table 91. HEC Pharm Company Information Table 92. HEC Pharm Business Overview Table 93. HEC Pharm Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. HEC Pharm Oral Retinoids Product Portfolio Table 95. HEC Pharm Recent Development Table 96. Zydus Company Information Table 97. Zydus Business Overview Table 98. Zydus Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Zydus Oral Retinoids Product Portfolio Table 100. Zydus Recent Development Table 101. Upsher-Smith Company Information Table 102. Upsher-Smith Business Overview Table 103. Upsher-Smith Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Upsher-Smith Oral Retinoids Product Portfolio Table 105. Upsher-Smith Recent Development Table 106. Teva Company Information Table 107. Teva Business Overview Table 108. Teva Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Teva Oral Retinoids Product Portfolio Table 110. Teva Recent Development Table 111. Stiefel Laboratories Company Information Table 112. Stiefel Laboratories Business Overview Table 113. Stiefel Laboratories Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Stiefel Laboratories Oral Retinoids Product Portfolio Table 115. Stiefel Laboratories Recent Development Table 116. Sigmapharm Laboratories Company Information Table 117. Sigmapharm Laboratories Business Overview Table 118. Sigmapharm Laboratories Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Sigmapharm Laboratories Oral Retinoids Product Portfolio Table 120. Sigmapharm Laboratories Recent Development Table 121. Par Pharmaceutical Company Information Table 122. Par Pharmaceutical Business Overview Table 123. Par Pharmaceutical Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Par Pharmaceutical Oral Retinoids Product Portfolio Table 125. Par Pharmaceutical Recent Development Table 126. Mylan Company Information Table 127. Mylan Business Overview Table 128. Mylan Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Mylan Oral Retinoids Product Portfolio Table 130. Mylan Recent Development Table 131. Impax Laboratories Company Information Table 132. Impax Laboratories Business Overview Table 133. Impax Laboratories Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Impax Laboratories Oral Retinoids Product Portfolio Table 135. Impax Laboratories Recent Development Table 136. GlaxoSmithKline Company Information Table 137. GlaxoSmithKline Business Overview Table 138. GlaxoSmithKline Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. GlaxoSmithKline Oral Retinoids Product Portfolio Table 140. GlaxoSmithKline Recent Development Table 141. Galderma Laboratories Company Information Table 142. Galderma Laboratories Business Overview Table 143. Galderma Laboratories Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Galderma Laboratories Oral Retinoids Product Portfolio Table 145. Galderma Laboratories Recent Development Table 146. Fuji Pharma Company Information Table 147. Fuji Pharma Business Overview Table 148. Fuji Pharma Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Fuji Pharma Oral Retinoids Product Portfolio Table 150. Fuji Pharma Recent Development Table 151. Dr. Reddy's Laboratories Company Information Table 152. Dr. Reddy's Laboratories Business Overview Table 153. Dr. Reddy's Laboratories Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Dr. Reddy's Laboratories Oral Retinoids Product Portfolio Table 155. Dr. Reddy's Laboratories Recent Development Table 156. Bausch Health Company Information Table 157. Bausch Health Business Overview Table 158. Bausch Health Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Bausch Health Oral Retinoids Product Portfolio Table 160. Bausch Health Recent Development Table 161. Barr Pharmaceuticals Company Information Table 162. Barr Pharmaceuticals Business Overview Table 163. Barr Pharmaceuticals Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. Barr Pharmaceuticals Oral Retinoids Product Portfolio Table 165. Barr Pharmaceuticals Recent Development Table 166. Amneal Pharmaceuticals Company Information Table 167. Amneal Pharmaceuticals Business Overview Table 168. Amneal Pharmaceuticals Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. Amneal Pharmaceuticals Oral Retinoids Product Portfolio Table 170. Amneal Pharmaceuticals Recent Development Table 171. Alembic Company Information Table 172. Alembic Business Overview Table 173. Alembic Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 174. Alembic Oral Retinoids Product Portfolio Table 175. Alembic Recent Development Table 176. Actavis Company Information Table 177. Actavis Business Overview Table 178. Actavis Oral Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 179. Actavis Oral Retinoids Product Portfolio Table 180. Actavis Recent Development Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Oral Retinoids Distributors List Table 184. Oral Retinoids Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Oral Retinoids Product Image Figure 2. Global Oral Retinoids Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Retinoids Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Retinoids Sales (2021-2032) & (K Units) Figure 5. Global Oral Retinoids Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oral Retinoids Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Alitretinoin Image Figure 9. Acitretin Image Figure 10. Bexarotene Image Figure 11. Tretinoin Image Figure 12. Isotretinoin Image Figure 13. Global Oral Retinoids Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Oral Retinoids Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Oral Retinoids Sales Market Share by Type (2021-2032) Figure 16. Global Oral Retinoids Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Oral Retinoids Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Oral Retinoids Revenue Market Share by Type (2021-2032) Figure 19. Hospital and Clinic Image Figure 20. Pharmacy Image Figure 21. Other Image Figure 22. Global Oral Retinoids Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Oral Retinoids Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Oral Retinoids Sales Market Share by Application (2021-2032) Figure 25. Global Oral Retinoids Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Oral Retinoids Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Oral Retinoids Revenue Market Share by Application (2021-2032) Figure 28. North America Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Oral Retinoids Sales Market Share by Country (2021-2032) Figure 30. U.S. Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Oral Retinoids Sales Market Share by Country (2021-2032) Figure 35. Germany Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Oral Retinoids Sales Market Share by Country (2021-2032) Figure 42. China Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Oral Retinoids Sales Market Share by Country (2021-2032) Figure 50. Brazil Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Oral Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Oral Retinoids Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Oral Retinoids Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Oral Retinoids Revenue (2021-2032) & (US$ Million) Figure 61. North America Oral Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Oral Retinoids Revenue (2021-2032) & (US$ Million) Figure 63. Europe Oral Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Oral Retinoids Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Oral Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Oral Retinoids Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Oral Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Oral Retinoids Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Oral Retinoids Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Alitretinoin
  • Acitretin
  • Bexarotene
  • Tretinoin
  • Isotretinoin
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Chongqing Huapont Pharmaceutical
  • Sichuan Med-Shine Pharmaceutical
  • Shandong Liangfu Pharmaceutical
  • Heilongjiang Fuhe Pharmaceutical
  • Harbin Dazhong Pharmaceutical
  • HEC Pharm
  • Zydus
  • Upsher-Smith
  • Teva
  • Stiefel Laboratories
  • Sigmapharm Laboratories
  • Par Pharmaceutical
  • Mylan
  • Impax Laboratories
  • GlaxoSmithKline
  • Galderma Laboratories
  • Fuji Pharma
  • Dr. Reddy's Laboratories
  • Bausch Health
  • Barr Pharmaceuticals
  • Amneal Pharmaceuticals
  • Alembic
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral Retinoids Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral Retinoids Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oral Retinoids Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oral Retinoids Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oral Retinoids Market Dynamics
  1. 2.1 Oral Retinoids Industry Trends
  2. 2.2 Oral Retinoids Industry Drivers
  3. 2.3 Oral Retinoids Industry Opportunities and Challenges
  4. 2.4 Oral Retinoids Industry Restraints
3 Oral Retinoids Market by Manufacturers
  1. 3.1 Global Oral Retinoids Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oral Retinoids Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oral Retinoids Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oral Retinoids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Retinoids Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oral Retinoids Manufacturers, Product Type & Application
  7. 3.7 Global Oral Retinoids Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Retinoids Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Retinoids Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Retinoids Tier 1, Tier 2, and Tier 3
4 Oral Retinoids Market by Type
  1. 4.1 Oral Retinoids Type Introduction
  2. 4.1.1 Alitretinoin
  3. 4.1.2 Acitretin
  4. 4.1.3 Bexarotene
  5. 4.1.4 Tretinoin
  6. 4.1.5 Isotretinoin
  7. 4.2 Global Oral Retinoids Sales by Type
  8. 4.2.1 Global Oral Retinoids Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Oral Retinoids Sales by Type (2021-2032)
  10. 4.2.3 Global Oral Retinoids Sales Market Share by Type (2021-2032)
  11. 4.3 Global Oral Retinoids Revenue by Type
  12. 4.3.1 Global Oral Retinoids Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Oral Retinoids Revenue by Type (2021-2032)
  14. 4.3.3 Global Oral Retinoids Revenue Market Share by Type (2021-2032)
5 Oral Retinoids Market by Application
  1. 5.1 Oral Retinoids Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Oral Retinoids Sales by Application
  6. 5.2.1 Global Oral Retinoids Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral Retinoids Sales by Application (2021-2032)
  8. 5.2.3 Global Oral Retinoids Sales Market Share by Application (2021-2032)
  9. 5.3 Global Oral Retinoids Revenue by Application
  10. 5.3.1 Global Oral Retinoids Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Oral Retinoids Revenue by Application (2021-2032)
  12. 5.3.3 Global Oral Retinoids Revenue Market Share by Application (2021-2032)
6 Global Oral Retinoids Sales by Region
  1. 6.1 Global Oral Retinoids Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Retinoids Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Retinoids Sales by Region (2021-2026)
  4. 6.2.2 Global Oral Retinoids Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oral Retinoids Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oral Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oral Retinoids Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oral Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oral Retinoids Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oral Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oral Retinoids Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oral Retinoids Revenue by Region
  1. 7.1 Global Oral Retinoids Revenue by Region
  2. 7.1.1 Global Oral Retinoids Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oral Retinoids Revenue by Region (2021-2026)
  4. 7.1.3 Global Oral Retinoids Revenue by Region (2027-2032)
  5. 7.1.4 Global Oral Retinoids Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oral Retinoids Revenue (2021-2032)
  8. 7.2.2 North America Oral Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oral Retinoids Revenue (2021-2032)
  11. 7.3.2 Europe Oral Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oral Retinoids Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oral Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oral Retinoids Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oral Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Huapont Pharmaceutical
  2. 8.1.1 Chongqing Huapont Pharmaceutical Company Information
  3. 8.1.2 Chongqing Huapont Pharmaceutical Business Overview
  4. 8.1.3 Chongqing Huapont Pharmaceutical Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Huapont Pharmaceutical Oral Retinoids Product Portfolio
  6. 8.1.5 Chongqing Huapont Pharmaceutical Recent Developments
  7. 8.2 Sichuan Med-Shine Pharmaceutical
  8. 8.2.1 Sichuan Med-Shine Pharmaceutical Company Information
  9. 8.2.2 Sichuan Med-Shine Pharmaceutical Business Overview
  10. 8.2.3 Sichuan Med-Shine Pharmaceutical Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Med-Shine Pharmaceutical Oral Retinoids Product Portfolio
  12. 8.2.5 Sichuan Med-Shine Pharmaceutical Recent Developments
  13. 8.3 Shandong Liangfu Pharmaceutical
  14. 8.3.1 Shandong Liangfu Pharmaceutical Company Information
  15. 8.3.2 Shandong Liangfu Pharmaceutical Business Overview
  16. 8.3.3 Shandong Liangfu Pharmaceutical Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Liangfu Pharmaceutical Oral Retinoids Product Portfolio
  18. 8.3.5 Shandong Liangfu Pharmaceutical Recent Developments
  19. 8.4 Heilongjiang Fuhe Pharmaceutical
  20. 8.4.1 Heilongjiang Fuhe Pharmaceutical Company Information
  21. 8.4.2 Heilongjiang Fuhe Pharmaceutical Business Overview
  22. 8.4.3 Heilongjiang Fuhe Pharmaceutical Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Heilongjiang Fuhe Pharmaceutical Oral Retinoids Product Portfolio
  24. 8.4.5 Heilongjiang Fuhe Pharmaceutical Recent Developments
  25. 8.5 Harbin Dazhong Pharmaceutical
  26. 8.5.1 Harbin Dazhong Pharmaceutical Company Information
  27. 8.5.2 Harbin Dazhong Pharmaceutical Business Overview
  28. 8.5.3 Harbin Dazhong Pharmaceutical Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Harbin Dazhong Pharmaceutical Oral Retinoids Product Portfolio
  30. 8.5.5 Harbin Dazhong Pharmaceutical Recent Developments
  31. 8.6 HEC Pharm
  32. 8.6.1 HEC Pharm Company Information
  33. 8.6.2 HEC Pharm Business Overview
  34. 8.6.3 HEC Pharm Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 HEC Pharm Oral Retinoids Product Portfolio
  36. 8.6.5 HEC Pharm Recent Developments
  37. 8.7 Zydus
  38. 8.7.1 Zydus Company Information
  39. 8.7.2 Zydus Business Overview
  40. 8.7.3 Zydus Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Zydus Oral Retinoids Product Portfolio
  42. 8.7.5 Zydus Recent Developments
  43. 8.8 Upsher-Smith
  44. 8.8.1 Upsher-Smith Company Information
  45. 8.8.2 Upsher-Smith Business Overview
  46. 8.8.3 Upsher-Smith Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Upsher-Smith Oral Retinoids Product Portfolio
  48. 8.8.5 Upsher-Smith Recent Developments
  49. 8.9 Teva
  50. 8.9.1 Teva Company Information
  51. 8.9.2 Teva Business Overview
  52. 8.9.3 Teva Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Oral Retinoids Product Portfolio
  54. 8.9.5 Teva Recent Developments
  55. 8.10 Stiefel Laboratories
  56. 8.10.1 Stiefel Laboratories Company Information
  57. 8.10.2 Stiefel Laboratories Business Overview
  58. 8.10.3 Stiefel Laboratories Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Stiefel Laboratories Oral Retinoids Product Portfolio
  60. 8.10.5 Stiefel Laboratories Recent Developments
  61. 8.11 Sigmapharm Laboratories
  62. 8.11.1 Sigmapharm Laboratories Company Information
  63. 8.11.2 Sigmapharm Laboratories Business Overview
  64. 8.11.3 Sigmapharm Laboratories Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sigmapharm Laboratories Oral Retinoids Product Portfolio
  66. 8.11.5 Sigmapharm Laboratories Recent Developments
  67. 8.12 Par Pharmaceutical
  68. 8.12.1 Par Pharmaceutical Company Information
  69. 8.12.2 Par Pharmaceutical Business Overview
  70. 8.12.3 Par Pharmaceutical Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Par Pharmaceutical Oral Retinoids Product Portfolio
  72. 8.12.5 Par Pharmaceutical Recent Developments
  73. 8.13 Mylan
  74. 8.13.1 Mylan Company Information
  75. 8.13.2 Mylan Business Overview
  76. 8.13.3 Mylan Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Mylan Oral Retinoids Product Portfolio
  78. 8.13.5 Mylan Recent Developments
  79. 8.14 Impax Laboratories
  80. 8.14.1 Impax Laboratories Company Information
  81. 8.14.2 Impax Laboratories Business Overview
  82. 8.14.3 Impax Laboratories Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Impax Laboratories Oral Retinoids Product Portfolio
  84. 8.14.5 Impax Laboratories Recent Developments
  85. 8.15 GlaxoSmithKline
  86. 8.15.1 GlaxoSmithKline Company Information
  87. 8.15.2 GlaxoSmithKline Business Overview
  88. 8.15.3 GlaxoSmithKline Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 GlaxoSmithKline Oral Retinoids Product Portfolio
  90. 8.15.5 GlaxoSmithKline Recent Developments
  91. 8.16 Galderma Laboratories
  92. 8.16.1 Galderma Laboratories Company Information
  93. 8.16.2 Galderma Laboratories Business Overview
  94. 8.16.3 Galderma Laboratories Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Galderma Laboratories Oral Retinoids Product Portfolio
  96. 8.16.5 Galderma Laboratories Recent Developments
  97. 8.17 Fuji Pharma
  98. 8.17.1 Fuji Pharma Company Information
  99. 8.17.2 Fuji Pharma Business Overview
  100. 8.17.3 Fuji Pharma Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Fuji Pharma Oral Retinoids Product Portfolio
  102. 8.17.5 Fuji Pharma Recent Developments
  103. 8.18 Dr. Reddy's Laboratories
  104. 8.18.1 Dr. Reddy's Laboratories Company Information
  105. 8.18.2 Dr. Reddy's Laboratories Business Overview
  106. 8.18.3 Dr. Reddy's Laboratories Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Dr. Reddy's Laboratories Oral Retinoids Product Portfolio
  108. 8.18.5 Dr. Reddy's Laboratories Recent Developments
  109. 8.19 Bausch Health
  110. 8.19.1 Bausch Health Company Information
  111. 8.19.2 Bausch Health Business Overview
  112. 8.19.3 Bausch Health Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Bausch Health Oral Retinoids Product Portfolio
  114. 8.19.5 Bausch Health Recent Developments
  115. 8.20 Barr Pharmaceuticals
  116. 8.20.1 Barr Pharmaceuticals Company Information
  117. 8.20.2 Barr Pharmaceuticals Business Overview
  118. 8.20.3 Barr Pharmaceuticals Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Barr Pharmaceuticals Oral Retinoids Product Portfolio
  120. 8.20.5 Barr Pharmaceuticals Recent Developments
  121. 8.21 Amneal Pharmaceuticals
  122. 8.21.1 Amneal Pharmaceuticals Company Information
  123. 8.21.2 Amneal Pharmaceuticals Business Overview
  124. 8.21.3 Amneal Pharmaceuticals Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Amneal Pharmaceuticals Oral Retinoids Product Portfolio
  126. 8.21.5 Amneal Pharmaceuticals Recent Developments
  127. 8.22 Alembic
  128. 8.22.1 Alembic Company Information
  129. 8.22.2 Alembic Business Overview
  130. 8.22.3 Alembic Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Alembic Oral Retinoids Product Portfolio
  132. 8.22.5 Alembic Recent Developments
  133. 8.23 Actavis
  134. 8.23.1 Actavis Company Information
  135. 8.23.2 Actavis Business Overview
  136. 8.23.3 Actavis Oral Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Actavis Oral Retinoids Product Portfolio
  138. 8.23.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Retinoids Value Chain Analysis
  2. 9.1.1 Oral Retinoids Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Retinoids Production Mode & Process
  6. 9.2 Oral Retinoids Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Retinoids Distributors
  9. 9.2.3 Oral Retinoids Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst